The European Molecular Biology Organisation is inviting you to participate in the 2017 Conference on Advances in Stem Cells and Regenerative Medicine, taking place in Heidelberg, Germany on May 23 – 26, 2017.
The aim of this conference is to provide a comprehensive overview of various aspects of stem cell biology. The cellular and molecular properties of normal tissue stem cells will be discussed, as will the properties of the niches that maintain them. We will address alterations to stem cell function during ageing and in the context, and how stem cells can be used for regenerative purposes and for disease modelling. On this occasion a particular focus will be on ageing/metabolism and the link between these topics and tissue homeostasis/regeneration. These are emerging areas in the stem cell field, with considerable potential and huge societal relevance. Finally, the meeting will also focus on the emerging and state-of-the-art single cell transcriptome techniques that are uncovering novel insights into stem cell populations.
- Tissue stem cell specification/regulation and self-renewal
- Stem cell niche, signalling
- Stem cell aging and metabolism
- Single cell analysis of stem cell dynamics
- Principles of development for stem cell engineering
- Stem cell based disease modelling and drug discovery
- Re-evaluating strategies for transplantation
Regenerative medicine is based on the ability of stem cells to repair tissue damage. The regenerative capacity of endogenous stem cells decreases with age, is impaired in degenerative diseases, and deregulated in cancer. Our ability to maintain and restore normal tissue function therefore requires that we understand not only the identity, properties and function of normal stem cells, but also the processes that alter their function during ageing, and in disease states.
- Anne Brunet – Stanford University, USA
- Hans C. Clevers – Hubrecht Institute, The Netherlands
- Michele De Luca – University of Modena and Reggio Emilia, Italy
- Anna Bigas – Hospital del Mar Medical Research Institute (IMIM), Spain
- Clare Blackburn – The University of Edinburgh, UK Blanpain Cedric Blanpain University of Brussels, Belgium
- Joseph V. Bonventre – Brigham and Women’s Hospital, Harvard Medical School, USA
- Hongkui Deng – Peking University, China
- John Dick – University Health Network, Canada
- Stuart Forbes – The University of Edinburgh, UK
- Yukiko Gotoh – The University of Tokyo, Japan
- Anne Grapin-Botton – University of Copenhagen, Denmark
- Kim Jensen – University of Copenhagen, Denmark
- Gordon Keller – University Health Network, Canada
- Valter Longo – University of Southern California, USA
- Matthias Lutolf – Swiss Federal Institute of Technology Lausanne (EPFL), Switzerland
- Alfonso Martinez-Arias – University of Cambridge, UK Irene Miguel-Aliaga – Imperial College London, UK
- Sean J. Morrison – The University of Texas Southwestern Medical Center, USA
- Christine L. Mummery – Leiden University Medical Center, The Netherlands
- Claus Nerlov – The University of Oxford, UK
- Christina Scheel – Helmholtz Zentrum München, Germany
- Ben Simons – Cavendish Laboratory, TCM, University of Cambridge, United Kingdom
- Toshio Suda – Cancer Science Institute, National University of Singapore, Singapore
- Masayo Takahashi – RIKEN, Japan
- Naomi Taylor – IGMM, France
- Maria Elena Torres Padilla – Institute of Epigenetics and Stem Cells, Helmholtz Zentrum München, Germany
- Fiona Watt – King’s College London, UK
- Val Wilson – The University of Edinburgh, UK
- Shosei Yoshida – National Institute for Basic Biology, Japan
Limited financial assistance is available for our events in the form of both registration fee waivers and travel grants. Availability will be indicated during the abstract or motivation letter submission process. Your place in the meeting is only confirmed by paying the registration fee, which is mandatory even when receiving a fee waiver.
Registration Fee Waiver
The fee waiver will cover the registration sum that you have paid to attend the meeting.
The travel grant will cover the cost of travel (airfare, train, bus, taxi, accommodation#, visa#) and is provided up to specified caps which are normally as follows:
- €400 for participants travelling to an EMBL Conference or EMBO|EMBL Symposium from within Europe.
- €1000 for participants travelling to an EMBL Conference or EMBO|EMBL Symposium from outside Europe.
- €500 for any participant travelling to an EMBO conference.
- €1000 for any participant working in India, Singapore or Taiwan travelling to an EMBO conference.
#not covered if the meeting is an EMBO conference.
These caps are subject to reduction at the organiser’s discretion to accommodate more participants. Recipients will be notified of their travel cap amount when they are informed of the outcome of their application. Original receipts must be provided with your signature for all costs incurred within two months of completion of travel. Scanned copies cannot be accepted.
- Clare Blackburn – The University of Edinburgh, UK
- Thomas Graf – Centre for Genomic Regulation (CRG), Spain
- Claus Nerlov – The University of Oxford, UK
- Donal O’Carroll – The University of Edinburgh, UK
- Olivier Pourquié – Harvard University, USA and PluriMes
- Shahragim Tajbakhsh – Pasteur Institute, France and REVIVE